.Merck beats revenues expectations, increases purchases overview on sturdy requirement for best medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Estimates as Keytruda Purchases Increase BloombergMerck Stock: Pharma Giant Posts Powerful Results, Yet Outlook Falls Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats earnings and also sales expectations surrounded by Keytruda asset, but gives combined full-year expectation MarketWatch.